Géraldine Garavel

A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo

Christiane Kofink, Nicole Trainor, Barbara Mair et al. · Nature Communications · 2022 · 206 citations · Full text

Medicine, Molecular Biology, Oncology +15

Intracellular Trapping of the Selective Phosphoglycerate Dehydrogenase (PHGDH) Inhibitor <b>BI-4924</b> Disrupts Serine Biosynthesis

Harald Weinstabl, Matthias Treu, Joerg Rinnenthal et al. · Journal of Medicinal Chemistry · 2019 · 87 citations · Full text

Pharmacy, Biochemistry, Medicinal Chemistry +15

Single Bead Labeling Method for Combining Confocal Fluorescence On-Bead Screening and Solution Validation of Tagged One-Bead One-Compound Libraries

Martin Hintersteiner, Thierry Kimmerlin, Frank Kalthoff et al. · Chemistry & Biology · 2009 · 63 citations · Full text

Pharmacy, Biochemistry, Molecular Biology +17

Targeted Synthesis of Complex Spiro[3<i>H</i>‐indole‐3,2′‐pyrrolidin]‐2(1<i>H</i>)‐ones by Intramolecular Cyclization of Azomethine Ylides: Highly Potent MDM2–p53 Inhibitors

Andreas Gollner, Harald Weinstabl, Julian E. Fuchs et al. · ChemMedChem · 2018 · 28 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

A Highly Potent and Cellularly Active β‐Peptidic Inhibitor of the p53/hDM2 Interaction

Martin Hintersteiner, Thierry Kimmerlin, Géraldine Garavel et al. · ChemBioChem · 2009 · 21 citations

Medicine, Medicinal Chemistry, Pharmacology +15